Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Nuvo Pharmaceuticals Inc MRVFF

Healthcare Drug Manufacturers - Specialty & Generic
Nuvo Pharmaceuticals Inc is a Canadian focused healthcare company doing business as Miravo Healthcare with global reach and a diversified portfolio of commercial products. Its product targets several therapeutic areas, including pain, allergy, and dermatology. The company's strategy is to in-license and acquire growth-oriented, complementary products for Canadian and international markets.


OTCQX:MRVFF - Post by User

Nuvo Pharmaceuticals Inc > Buyout
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(2138)
•••
Comment by lscfaon Feb 07, 2023 5:28pm
157 Views
Post# 35273064

RE:RE:RE:RE:RE:RE:RE:RE:Buyout

RE:RE:RE:RE:RE:RE:RE:RE:Buyoutvote no.....


lscfa wrote: Tables of peers...

 

$ 000 Cdn

Miravo

Medexus

Biosyent

Bloom TP

1.20

1.50

10.00

Shs o/s

11.4

19.6

12.3

Mkt cap

13.7

29.4

123.0

Net debt

75.0

79

-27.8

Ent. Value

88.7

108.4

95.2

2023 ebitda

21.7

14

9.5

EV/ ebitda

4.1

7.7

10.0

 



<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities